According to SCHOTT Pharma's latest financial reports the company has a price-to-book ratio of 3.49344.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2024-12-31 | 4.53 | -35.45% |
2023-12-31 | 7.02 | |
2022-12-31 | N/A |